You are here

  • Home
  • Archive
  • Volume 9, Issue 1
  • Fecal calprotectin concentration to assess endoscopic and histologic remission in patients with cancer with immune-mediated diarrhea and colitis

Article metrics

Article menu
Clinical/translational cancer immunotherapy
Original research
Fecal calprotectin concentration to assess endoscopic and histologic remission in patients with cancer with immune-mediated diarrhea and colitis

 

Online download statistics by month:

Online download statistics by month: January 2021 to March 2026

AbstractFullPdf
Jan 202136136476
Feb 202115615737
Mar 202110310334
Apr 2021919118
May 202111311326
Jun 202110310317
Jul 202111011016
Aug 202113713718
Sep 202111211233
Oct 202111011027
Nov 202112312336
Dec 202112612622
Jan 2022979819
Feb 2022606028
Mar 2022767741
Apr 2022717425
May 202210310312
Jun 2022858721
Jul 20229810024
Aug 202211211631
Sep 202210410621
Oct 2022939422
Nov 2022838628
Dec 2022727210
Jan 2023858515
Feb 202311211421
Mar 2023848514
Apr 2023737323
May 2023787816
Jun 202383849
Jul 2023868619
Aug 2023686810
Sep 2023606014
Oct 2023858520
Nov 2023767617
Dec 202311412025
Jan 2024555722
Feb 2024585822
Mar 202412112257
Apr 202410210330
May 202418818820
Jun 202411311413
Jul 202410711224
Aug 2024979815
Sep 2024687120
Oct 2024828222
Nov 2024909221
Dec 2024757919
Jan 202511111328
Feb 2025878937
Mar 2025939336
Apr 2025949444
May 2025979934
Jun 2025585817
Jul 2025110
Aug 2025110
Mar 2026110
Total540254611326